A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsXiaomei Zhang, Michael T. Lewis, Sofie Claerhout et al.|Cancer Research|2013Cited by 485
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rachel Schiff, Rinath Jeselsohn et al.|Proceedings of the National Academy of Sciences|2016Cited by 185
Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II StudyC. Kent Osborne, Mark Sellers, Patrick Neven et al.|Clinical Cancer Research|2011Cited by 181
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 BlockadeAleix Prat, Mothaffar F. Rimawi, Tomás Pascual et al.|JNCI Journal of the National Cancer Institute|2019Cited by 168
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 TherapyMario Giuliano, Rachel Schiff, Huizhong Hu et al.|Clinical Cancer Research|2015Cited by 119